GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 129 filers reported holding GW PHARMACEUTICALS PLC in Q2 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $88,000 | +7.3% | 789 | +27.5% | 0.00% | 0.0% |
| Q3 2016 | $82,000 | -15.5% | 619 | -41.5% | 0.00% | 0.0% |
| Q2 2016 | $97,000 | +410.5% | 1,058 | +296.3% | 0.00% | +200.0% |
| Q1 2016 | $19,000 | +18.8% | 267 | +12.7% | 0.00% | 0.0% |
| Q4 2015 | $16,000 | -57.9% | 237 | -42.3% | 0.00% | -66.7% |
| Q3 2015 | $38,000 | +375.0% | 411 | +532.3% | 0.00% | +200.0% |
| Q2 2015 | $8,000 | +60.0% | 65 | +30.0% | 0.00% | – |
| Q1 2015 | $5,000 | -37.5% | 50 | -60.0% | 0.00% | -100.0% |
| Q4 2014 | $8,000 | -20.0% | 125 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $10,000 | -47.4% | 125 | -28.6% | 0.00% | -66.7% |
| Q2 2014 | $19,000 | +58.3% | 175 | -12.5% | 0.00% | +200.0% |
| Q1 2014 | $12,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |